StockData
Autolus Therapeutics plc logo

Autolus Therapeutics plc (AUTL) stock

AUTLNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 5/3020% below fair value
$1.09−0.05 (-4.39%)

Close on Nov 17, 2026Market cap $290.12MP/E –Yield –

Autolus Therapeutics cash

Cash and short-term investments held at the end of each period.

Autolus Therapeutics's cash was $201.63M at Jun 30, 2026. For fiscal 2025 it was $300.71M, down 49.0% from the year before. The highest annual figure on record is $589.45M in fiscal 2024.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$300.71M-49.0%
FY2024Dec 31, 2024$589.45M+145.3%
FY2023Dec 31, 2023$240.34M-37.2%
FY2022Dec 31, 2022$382.76M+23.3%
FY2021Dec 31, 2021$310.34M+101.4%
FY2020Dec 31, 2020$154.09M-37.6%
FY2018Sep 30, 2018$246.98M+80.2%
FY2017Sep 30, 2017$137.07M+388.5%
FY2016Sep 30, 2016$28.06M+175.0%
FY2015Sep 30, 2015$10.20M–

Quarterly cash

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q2 FY2026CQ2 2026Jun 30, 2026$201.63M-55.6%
Q1 FY2026CQ1 2026Mar 31, 2026$229.43M-55.6%
Q4 FY2025CQ4 2025Dec 31, 2025$300.71M-49.0%
Q3 FY2025CQ3 2025Sep 30, 2025$367.41M-44.1%
Q2 FY2025CQ2 2025Jun 30, 2025$454.28M-35.6%
Q1 FY2025CQ1 2025Mar 31, 2025$516.58M-31.9%
Q4 FY2024CQ4 2024Dec 31, 2024$589.45M+145.3%
Q3 FY2024CQ3 2024Sep 30, 2024$657.07M+156.3%
Q2 FY2024CQ2 2024Jun 30, 2024$705.94M+129.6%
Q1 FY2024CQ1 2024Mar 31, 2024$758.53M+121.1%
Q4 FY2023CQ4 2023Dec 31, 2023$240.34M-37.2%
Q3 FY2023CQ3 2023Sep 30, 2023$256.42M+57.3%
Q2 FY2023CQ2 2023Jun 30, 2023$307.50M+42.1%
Q1 FY2023CQ1 2023Mar 31, 2023$343.03M+27.7%
Q4 FY2022CQ4 2022Dec 31, 2022$382.76M+23.3%
Q3 FY2022CQ3 2022Sep 30, 2022$163.05M-31.8%
Q2 FY2022CQ2 2022Jun 30, 2022$216.44M+40.5%
Q1 FY2022CQ1 2022Mar 31, 2022$268.56M+51.1%
Q4 FY2021CQ4 2021Dec 31, 2021$310.34M+46.4%
Q1 FY2021CQ1 2021Mar 31, 2021$239.01M-1.8%
Q4 FY2020CQ4 2020Dec 31, 2020$154.09M-37.6%
Q3 FY2020CQ3 2020Sep 30, 2020$177.70M-32.9%
Q2 FY2020CQ2 2020Jun 30, 2020$212.04M+64.4%
Q1 FY2020CQ1 2020Mar 31, 2020$243.31M+77.5%
Q4 FY2018CQ3 2018Sep 30, 2018$246.98M+780.2%
Q3 FY2018CQ2 2018Jun 30, 2018$264.92M+2496.5%
Q1 FY2018CQ4 2017Dec 31, 2017$128.98M–
Q4 FY2017CQ3 2017Sep 30, 2017$137.07M–
Q4 FY2016CQ3 2016Sep 30, 2016$28.06M–
Q4 FY2015CQ3 2015Sep 30, 2015$10.20M–

More Autolus Therapeutics figures

See a number that looks wrong?